Case-control study on perfluorinated alkyl acids (PFAAs) and the risk of prostate cancer

Environment International

Volumn 63, Issue , 2014, Pages 35-39

  Hardell, Elin ^a   Kärrman, Anna ^a   van Bavel, Bert ^a   Bao, Jia ^a   Carlberg, Michael ^b   Hardell, Lennart ^b  

^a ÖREBRO UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Heredity; PFOA; PFOS; Prostate cancer; Risk factors

Indexed keywords

BLOOD; CARBOXYLATION; CHEMOTHERAPY; HEALTH RISKS;

HEREDITY; PFOA; PFOS; PROSTATE CANCERS; RISK FACTORS;

DISEASES;

CARBOXYLIC ACID DERIVATIVE; PERFLUORO COMPOUND; PERFLUOROHEXANE SULFONATE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; PROSTATE ANTIGEN; UNCLASSIFIED DRUG;

CANCER; CHEMICAL POLLUTANT; HEALTH RISK; RISK FACTOR; SURFACTANT;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; GENOTYPE ENVIRONMENT INTERACTION; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLLUTION; PRIORITY JOURNAL; PROSTATE CANCER;

HEREDITY; PFOA; PFOS; PROSTATE CANCER; RISK FACTORS;

AGED; ALKANESULFONATES; CARBOXYLIC ACIDS; CASE-CONTROL STUDIES; ENVIRONMENTAL POLLUTANTS; FLUOROCARBONS; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK; SWEDEN;

EID: 84887579728     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2013.10.005     Document Type: Article

References (37)

1. 3M Company The science of organic fluorochemistry 1999, [Document no. AR226-0547].
2. 3M Company Environmental and health assessment of perfluorooctanesulfonate and its salts. US EPA Administrative Record 2003, [Document no. AR-226-1486].
3. Alexander B.H., Olsen G.W. Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers. Ann Epidemiol 2007, 17:471-478.
4. Alexander B.H., Olsen G.W., Burris J.M., Mandel J.H., Mandel J.S. Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup Environ Med 2003, 60:722-729.
5. Baccarelli A., Pfeiffer A., Consonni D., Pesatori A.C., Bonzini M., Patterson D.G., et al. Handling of dioxin measurement data in the presence of non-detectable values: overview of available methods and their application in the Seveso chloracne study. Chemosphere 2005, 60:898-906.
6. Bonefeld-Jorgensen E.C., Long M., Bossi R., Asmund G., Krüger T., Ghisari M., et al. Perfluorinated compounds are related to breast cancer risk in Greenland Inuit: a case control study. Environ Health 2011, 10:88.
7. Buck R.C., Franklin J., Berger U., Conder J.M., Cousins I.T., de Voogt P., et al. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr Environ Assess Manag 2011, 7:513-541.
8. Carloni D. Perfluorooctane sulfonate (PFOS) production and use: past and current evidence 2009, 1-38. UNIDO.
9. Eriksen K.T., Sørensen M., McLaughlin J.K., Lipworth L., Tjønneland A., Overvad K., et al. Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J Natl Cancer Inst 2009, 101:605-609.
10. Eriksen K.T., Sørensen M., McLaughlin J.K., Tjønneland A., Overvad K., Raaschou-Nielsen O. Determinants of plasma PFOA and PFOS levels among 652 Danish men. Environ Sci Technol 2011, 45:8137-8145.
11. Fromme H., Tittlemier S.A., Völker W., Wilhelm M., Twardella D. Perfluorinated compounds - exposure assessment for the general population in western countries. Int J Hyg Environ Health 2009, 212:239-270.
12. Giesy J.P., Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 2001, 35:1339-1342.
13. Gilliland F.D., Mandel J.S. Mortality among employees of a perfluorooctanoic acid production plant. J Occup Med 1993, 35:950-954.
14. Grice M.M., Alexander B.H., Hoffbeck R., Kampa D.M. Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J Occup Environ Med 2007, 49:722-729.
15. Haug L., Thomsen C., Becher G. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ Sci Technol 2009, 43:2131-2136.
16. Hundley S.G., Sarrif A.M., Kennedy G.L. Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. Drug Chem Toxicol 2006, 29:137-145.
17. Johnson J.D., Gibson S.J., Ober R.E. Absorption of FC-95-14C in rats after a single oral dose. US EPA Administrative Record 1979, Riker Laboratories, Inc., St Paul, MN, [AR-226-0007].
18. Key B.D., Howell R.D., Criddle C.S. Fluorinated organic in the biosphere. Environ Sci Technol 1997, 31:2445-2454.
19. Key B.D., Howell R.D., Criddle C.S. Defluorination of organofluorine sulfur compounds by Pseudomonas sp. Strain D2. Environ Sci Technol 1998, 32:2283-2287.
20. Kissa E. Fluorinated surfactants and repellants 2001, Marcel Decker, New York. 2nd ed.
21. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007, 99:366-394.
22. Leonard R.C., Kreckmann K.H., Sakr C.J., Symons J.M. Retrospective cohort mortality study of workers in a polymer production plant including reference population of regional workers. Ann Epidemiol 2008, 18:15-22.
23. Lindström G., Kärrman A., van Bavel B. Accuracy and precision in the determination of perfluorinated chemicals in human blood verified by interlaboratory comparisons. J Chromatogr 2009, 1216:394-400.
24. Lundin J.I., Alexander B.H., Olsen G.W., Church T.R. Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 2009, 20:921-928.
25. Olsen G.W., Mair D.C., Reagen W.K., Ellefson M.E., Ehresman D.J., Butenhoff J.L., et al. Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. Chemosphere 2007, 68:105-111.
26. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Buttenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007, 115:1298-1305.
27. Patel A.R., Klein E.A. Risk factors for prostate cancer. Nat Clin Pract Urol 2009, 6:87-95.
28. Paul A.G., Jones K.C., Sweetman A.J. A first global production, emission, and environmental inventory for perfluorooctane sulfonate. Environ Sci Technol 2009, 43:386-392.
29. Powley C.R., George S.W., Ryan T.W., Buck R.C. Matrix effect-free analytical methods for determination of perfluorinated carboxylic acids in environmental matrices. Anal Chem 2005, 77:6353-6358.
30. Prescher D., Gross U., Wotzka J., Txcheu-Schlueter M., Starke W. Environmental behavior of fluoro surfactants: part 2: study on biochemical degradability. Acta Hydrochim Hydrobiol 1985, 13:17-24.
31. Saito N., Harada K., Inoue K., Sasaki K., Yoshinaga T., Koizumi A. Perfluorooctanoate and perfluorooctane sulfonate concentrations in surface water in Japan. J Occup Health 2004, 46:49-59.
32. Seacat A.M., Thomford P.J., Hansen K.J., Olsen G.W., Case M.T., Butenhoff J.L. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci 2002, 68:249-264.
33. Seacat A.M., Thomford P.J., Hansen K.J., Clemen L.A., Eldridge S.R., Elcombe C.R., et al. Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 2003, 183:117-131.
34. So M.K., Yamashita N., Taniyasu S., Jiang Q., Giesy J.P., Chen K., et al. Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhouushan, China. Environ Sci Technol 2004, 40:2924-2929.
35. Socialstyrelsen Cancer incidence in Sweden 2011 [internet] [cited 2013 February 6] Available from:. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18919/2012-12-19.pdf.
36. Trudel D., Horowitz L., Wormuth M., Scheringer M., Cousins I.T., Hungerbühler K. Estimating consumer exposure to PFOS and PFOA. Risk Anal 2008, 28:251-269.
37. UNEP The new POPs under the Stockholm Convention [Accessed: 21 December 2012]. http://chm.pops.int/Implementation/NewPOPs/TheNewPOPs/tabid/672/Default.aspx.